AI Enables Individualized Cancer Vaccines

Immunotherapies have become a key treatment area within oncology. In 2023 the global market size of this type of treatment was estimated to be worth $118.9 billion, and this is expected to more than double over the next decade, suggests Statista. Many of the big pharma companies that own immunotherapies are now looking to combination treatments to boost their efficacy, providing them with an edge in the highly competitive space. This has led some companies to explore cancer vaccines,